It is possible that the reduction of ACTG1 in asthma may promote the upregulation of ACTA2, and probably ACTB, thereby enhancing AHR through the activation of inhibitory pathways that prevent muscle relaxation, such as those regulated by ROCK. The gene discussed is ACTG1; the disease is asthma.